References
- Young, S.G. and Parthasarathy, S. Why are low-density lipoproteins atherogenic? West J. Med. 160: 153-164(1994)
- Bruce, C., Sharp, D.S. and Tall, A.R. Relationship of HDL and coronary heart disease to a common amino acid polymorphism in the cholesteryl ester transfer protein in men with and without hypertriglyceridemia. J. Lipid Res. 39: 1071-1078 (1998)
- Gunstone, F.D., Harwood, J.L. and Padley, F.B. The role of fats in human nutrition, pp. 7-15. In: The Lipid Handbook. Padley, F.B. and Podmore, J. (eds.). Ellis Horwood, Chichester, UK (1985)
- Brown, M.S. and Goldstein, J.L. Multivalent feedback regulation of HMG-CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth. J. Lipid Res. 21: 505-512 (1980)
- Spector, A.A. and Yorek, M.A. Membrane lipid composition and cellular function. J. Lipid Res. 26: 1015-1021 (1985)
- Heider, J.G., Pickens, C.E. and Kelly, L.A. Role of acyl CoA:Cholesterol acyltransferase in cholesterol absorption and its inhibition by 57-118 in the rabbit. J. Lipid Res. 24: 1127-1134 (1983)
- Crey, M.C., Sirtori, D.M. and Bliss, C.M. Lipid, digestion and adsoption. Ann. Rev. Physiol. 45: 651-658 (1983) https://doi.org/10.1146/annurev.ph.45.030183.003251
- Brown, M.S. and Goldstein, J.L. Regulation of plasma cholesterol by lipoprotein receptors. Science 212: 628-634 (1981) https://doi.org/10.1126/science.6261329
- Osborn, J.C. and Brewer, H.B. The plasma lipoproteins. Adv. Protein Chem. 31: 253-258 (1977) https://doi.org/10.1016/S0065-3233(08)60220-X
- Goldstein, D.S., Levinson, P.D., Zimlichman, R., Pitterman, A., Stull, R. and Keiser, H.R. Clonidine suppression testing in essential hypertention. Ann. Int. Med. 102: 42-48 (1985) https://doi.org/10.7326/0003-4819-102-1-42
- Insel, P.A. and Motulsky, H.J. A hypothesis linking intracellular sodium membrane receptors and hypertention. Life Sci. 34: 1009-1023 (1984) https://doi.org/10.1016/0024-3205(84)90013-4
- Croog, S.H., Levine, S., Testa, M.A., Brown, B., Bulpitt, C.J., Jekins, D., Klerman, G.L. and Willilams, G.H. The effects of antihypertensive therapy on the quality of life. New Engl. J. Med. 314: 1657-1664 (1986) https://doi.org/10.1056/NEJM198606263142602
- Brown, M.S. and Goldstein, J.L. A receptor-mediated pathway for cholesterol homeostasis. Science 232: 34-47 (1986) https://doi.org/10.1126/science.3513311
- Endo, A. The discovery and development of HMG-CoA reductase inhibitors. J. Lipid Res. 33: 1569-1577 (1992)
- Brown, G., Albert, J.J., Fisher, L.D., Schaefer, S.M., Lin, J.T., Kaplan, C., Zhao, X.O., Bisson, B.D., Fitzpatrick, V.F. and Dodge, H.T. Regression of coronary artery disease as a result of intensive lipid lowering therapy in men with high levels of apolipoprotein. New Engl. J. Med. 323: 1289-1295 (1990) https://doi.org/10.1056/NEJM199011083231901
- Kane, J.P., Malloy, M.J., Ports, T.A., Philips, N.R., Diehl, J.C. and Havel, R.J. Regression of coronary atherosclerosis during treatment of familia hypercholesterolemia with combined drug regimens. JAMA 264, 3007-3015 (1990) https://doi.org/10.1001/jama.264.23.3007
- Bergstrom, J.D., Krutz, M.M., Rew, D.J., Amend, A.M., Karkas, J.D., Bostedor, RD., Bansal, V.S., Dufresns, C., Middleworth, FLV, Hensens, O.D., Liesch, J.M., Zinc, D.L., Wilson, K.E., Onishi, J., Milligan, lA., Bills, G., Kaplan, L., Nallin, M., Jenskins, R.G., Huang, L., Meinz, M.S., Quinn, L., Burg, R.U., Kong, Y.L., Mochales, S., Mojena, M., Martin, I., Pelaez, F, Diez M.T. and Albert, A.W Zaragozic acids: A family of metabolites that are picomolar competitive inhibitors of squalene synthase. Proc. Natl. Acad. Sci. 90: 80-89 (1993) https://doi.org/10.1073/pnas.90.1.80
- Dawson, M.J., Farthing, J.E., Marshall, P.S., Middleton, R.E., O'Neill, M.J., Shuttleworth, A., Stylli, C., Tait, R.M., Taylor, P.M., Wildman, H.G., Buss, A.D., Langley, D. and Hayes, M.V. The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. I. Taxonomy, fermentation, isolation, physicochemical properties and biological activity. J. Antibiotics 45: 639-647 (1992) https://doi.org/10.7164/antibiotics.45.639
- Sidebottom, P.J.R. Highcock, M., Lane, S.J., Procopiou, P.A. and Watson, N.S. The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. II. Structure elucidation. J. Antibiotics 45: 648-658 (1992) https://doi.org/10.7164/antibiotics.45.648
- Baxter, A, Fitzgerald, B.J., Hutson, J.L., McCarthy, A.D., Motteram, J.M., Ross, B.C., Sapra, M., Snowden, M.A., Watson, N.S., Williarm, R.J. and Wright, C. Squalestatin I, a potent inhibitor of squalene synthase, which lower serum cholesterol in vivo. J. BioI. Chem. 267: 11705-11708 (1992)
- Popjak, G., Goodman, D.S., Cornforth, J.W, Cornforth, R.H. and Ryhage, R. Studies on the biosynthesis of cholesterol: XV. Mechanism of squalene biosynthesis from famesyl pyrophosphate and from mevalonate. J. BioI. Chem. 236: 1934-1939 (1961)
- Porter, J.W. Biosynthesis of isoprenoid compounds, Vol. 1, pp. 413-441. In: Prenyl Transferases and Isomerase, Poulter, C.D. and Rilling, H.C. (eds.). Wiley Publisher, New York, USA (1981)
- Agnew, W.S. Squalene synthetase. Methods Enzymol. 110: 359-375 (1985) https://doi.org/10.1016/S0076-6879(85)10094-7
- Kuswik, R.G. and Rilling, H.C. Squalene synthetase. Solubilizationand partial purification of squalene synthetase, copurification of presqualene pyrophosphate and squalene synthetase activities. J.Biol.Chem. 262: 1505-1510 (1987)
- Cohen, L.H., Griffioen, A.M. and Wanders, R.J.A. Regulation of squalene synthase in rat liver. Biochem. Biophys. Res. Commun. 138: 335-341 (1986) https://doi.org/10.1016/0006-291X(86)90285-8
- Dugan, R.E. and Porter, J.W. Hog liver squalene synthase: The partial purification of the particulate enzyme and kinetic analysis of the reaction. Arch. Biochem. Biophys. 152: 28-35 (1972) https://doi.org/10.1016/0003-9861(72)90189-0
- Shechter, I., Klinger, I. and Rucher, M.L. Solubilization and characterization of a truncated form of rat hepatic squalene synthase. J. BioI. Chem. 267: 8628-8635 (1992)
- Toda, S., Miyase, T., Arichi, H., Tanizawa, H. and Takino, Y. Natural antioxidants. III. Antioxidative components isolated from rhizome of Curcuma longa L. Chem. Pharm. Bull. 33: 1725-1728 (1985) https://doi.org/10.1248/cpb.33.1725
- Kuttan, R, Bhanumathy, P., Nirmala, K. and George, M.C. Potential anticancer activity of tumeric (Curcuma Zanga). Cancer Lett. 29: 197-202 (1996) https://doi.org/10.1016/0304-3835(85)90159-4